Cytoreductive Surgery with HIPEC as Primary Treatment for Advanced Epithelial Ovarian Carcinoma: Upfront or Interval-ISPSM Collaborative Study.

Somashekhar, S P; Ramya, Y; Ashwin, K R; Fernandes, Aaron Marian; Ahuja, Vijay; Namachivayam, Arun Kumar; Kumar, C Rohit

Somashekhar, S P; Ramya, Y; Ashwin, K R; Fernandes, Aaron Marian; Ahuja, Vijay; Namachivayam, Arun Kumar; Kumar, C Rohit.

Afiliação

Somashekhar SP; Department of Surgical & Gynecological Oncology, Aster International Institute of Oncology, Aster Hospital, Bangalore, India.
Ramya Y; Apollo BGS Hospital, Mysore, India.
Ashwin KR; Department of Surgical & Gynecological Oncology, Aster International Institute of Oncology, Aster Hospital, Bangalore, India.
Fernandes AM; Department of Surgical & Gynecological Oncology, Aster International Institute of Oncology, Aster Hospital, Bangalore, India.
Ahuja V; Department of Surgical & Gynecological Oncology, Aster International Institute of Oncology, Aster Hospital, Bangalore, India.
Namachivayam AK; Department of Data Science, Alke Research Private Limited, Bengaluru, India.
Kumar CR; Department of Surgical & Gynecological Oncology, Aster International Institute of Oncology, Aster Hospital, Bangalore, India.

Indian J Surg Oncol ; 14(Suppl 1): 226-232, 2023 Jun.

Article em En | MEDLINE | ID: mdl-37359935

Palavras-chave

Advanced epithelial ovarian cancer; Interval CRS HPEC; Morbidity; Upfront CRS HIPEC; Upfront versus interval CRS HIPEC

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Indian J Surg Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google